Skip to main content
. 2020 Jan 13;105(5):489–495. doi: 10.1136/archdischild-2019-318474

Table 1.

Patient characteristics

Characteristic Entire study population
(n=91)
Group 1 (n=18) Group 2 (n=8) Group 3 (n=25) Group 4 (n=10) Group 5 (n=26) Group 6 (n=1) Group 7 (n=2) Group 8 (n=1)
Gestational age (week), median (IQR) 27.7
(25.9–30.6)
25.3 (24.8–25.6) 24.8 (24.4–25.6) 28.0 (26.9–28.9) 26.8 (26.3–27.1) 32.0 (30.4–33.6) 30.7 38.1 37.9
Birth weight (g), median (IQR) 1045
(825–1560)
720 (634–864) 740 (716–791) 1045 (890–1223) 938 (886–1076) 1678 (1480–2129) 1290 3845 2865
Birth weight <10th percentile, n (%) 23 (25) 5 (28) 0 8 (32) 1 (10) 8 (31) 1 (100) 0 0
Postnatal age (hour), median (IQR) 29
(9–213)
129 (38–173) 405 (384–681) 10
(6–31)
371 (307–524) 20
(5–26)
432 50 593
Actual weight (g), median (IQR) 1100
(830–1560)
705 (643–838) 923 (825–1084) 1065 (910–1193) 1105 (925–1123) 1678 (1460–2125) 1400 3848 3100
Male gender, n (%) 58 (64) 12 (67) 7 (88) 13 (52) 6 (60) 16 (62) 1 (100) 2 (100) 1 (100)
Reason for intubation, n (%)
 RDS 44 (48.4) 2 (11.1) 0 17 (68) 0 23 (88.5) 0 2 (100) 0
 Apnoea 19 (20.9) 9 (50) 5 (62.5) 2 (8) 3 (30) 0 0 0 0
 Sepsis/NEC 11 (12.1) 5 (27.8) 1 (12.5) 3 (12) 1 (10) 1 (3.8) 0 0 0
 Respiratory insufficiency 13 (14.3) 1 (5.6) 2 (25) 3 (12) 4 (40) 2 (7.7) 0 0 1 (100)
 Elective* 2 (2.2) 0 0 0 1 (10) 0 1 (100) 0 0
 Other 2 (2.2) 1 (5.6) 0 0 1 (10) 0 0 0 0
Propofol starting dose (mg/kg), n (%)
 0.5 1 (1) 1 6) 0 0 0 0 0 0 0
 1.0 30 (33) 4 (22) 5 (63) 5 (20) 6 (60) 6 (23) 1 (100) 2 (100) 1 (100)
 1.5 23 (25) 5 (28) 3 (37) 5 (20) 4 (40) 6 (23) 0 0 0
 1.75 9 (10) 0 0 5 (20) 0 4 15) 0 0 0
 2.0 26 (29) 6 (33) 0 10 (40) 0 10 (38) 0 0 0
 2.5 2 (2) 2 (11) 0 0 0 0 0 0 0

*Including prior to surgery or tube exchange.

NEC, necrotising enterocolitis; RDS, Respiratory Distress Syndrome.